For the first time, bioengineered heart valves implanted into lambs have been shown to grow with the recipient. If the same holds for humans, the new heart valves could provide an ‘off-the-shelf’, single-shot product for pediatric heart surgery. Currently, the only option for pediatric patients with heart defects is bioprosthetic valves made from chemically treated animal tissues. These generally calcify and do not grow with the child, thus multiple open-heart surgeries are required until the patient reaches adulthood when a mechanical valve can be implanted. Clearly, an engineered valve that can grow with the patient and does not calcify represents...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!